Can inflammation markers predict heart failure outcomes?

NCT ID NCT07320014

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This observational study will enroll 112 adults hospitalized for heart failure with preserved or mildly reduced ejection fraction. Researchers will collect blood and urine samples to measure inflammatory biomarkers and analyze genetic factors. The goal is to identify markers that predict complications and guide personalized treatment. Participation does not change standard medical care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could help doctors better predict which heart failure patients are at higher risk of complications, leading to more personalized care.

What could go wrong

This is an observational study, not a treatment trial, so it won't directly change patient care. Results may not apply to all heart failure patients, and genetic findings may not be actionable.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••